Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

This meta-analysis aimed to assess the diagnostic efficiency of blood-based septin 9 (SEPT9) methylation assay for the detection of colorectal cancer (CRC). Studies were searched in the Springer, Wiley, Cochrane Library, PubMed, Ovid, Embase, Web of Science, China BioMedicine, Wanfang and China National Knowledge Infrastructure databases until July 2017. Methodological quality assessment was performed based on the guidelines of the Quality Assessment of Diagnostic Accuracy Studies. According to 1/3 and 2/3 algorithms, the meta-analyses for the diagnostic effect of SEPT9 in CRC were compared with healthy subjects and subjects with polyps, adenoma, and non-CRC, respectively. The random effects model was applied and publication bias was evaluated. The included 29 studies comprised 10,486 subjects (3202 patients with CRC and 7284 controls). In comparison with healthy subjects, the pooled sensitivity with 95% confidence intervals (CIs) of SEPT9 methylation for the diagnosis of CRC was 0.74 (95% CI: 0.61–0.84) in the 1/3 algorithm group, whereas the specificity was 0.96 (95% CI: 0.95–0.97) in the 2/3 algorithm group. Additionally, positive likelihood ratio was less than 10 and negative likelihood ratio more than 0.1 in the 2/3 algorithm group for patients with CRC vs. polyps and adenoma. The P value of Deeks’ funnel plot was 0.36, suggesting that there was no publication bias. SEPT9 methylation can be used to diagnose CRC in healthy individuals under the 2/3 algorithm. The determination of SEPT9 methylation does not distinguish well between CRC and polyps or adenoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Aran V, Victorino AP, Thuler LC, Ferreira CG (2016) Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin Colorectal Cancer 15(3):195–203

    PubMed  Google Scholar 

  2. Christensen TD, Escoffery C, Plath J, Son HJ, Edwards SKE, Xu R (2017) Advances in colorectal neoplasms, pp 334

  3. Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383(9927):1490–1502

    Google Scholar 

  4. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115–132

    Google Scholar 

  5. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67(3):177–193

    PubMed  Google Scholar 

  6. Bae JM, Kim JH, Kang GH (2016) Molecular subtypes of colorectal cancer and their clinicopathologic features, with an emphasis on the serrated neoplasia pathway. Arch Pathol Lab Med 140(5):406–412

    CAS  PubMed  Google Scholar 

  7. El Bairi K, Tariq K, Himri I, Jaafari A, Smaili W, Kandhro AH, Gouri A, Ghazi B (2017) Decoding colorectal cancer epigenomics. Cancer Genet 220:49–76

    PubMed  Google Scholar 

  8. Shen L, Catalano PJ, Benson AB 3rd, O'Dwyer P, Hamilton SR, Issa JP (2007) Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clin Cancer Res 13(20):6093–6098

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T, Osborn N (2014) Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 63(2):317–325

    CAS  Google Scholar 

  10. Esteller M (2003) Relevance of DNA methylation in the management of cancer. Lancet Oncol 4(6):351–358

    CAS  PubMed  Google Scholar 

  11. Dong L, Ren H (2018) Blood-based DNA methylation biomarkers for early detection of colorectal Cancer. J Proteomics Bioinform 11(6):120–126

    PubMed  PubMed Central  Google Scholar 

  12. Ganepola GA, Nizin J, Rutledge JR, Chang DH (2014) Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer. World J Gastrointest Oncol 6(4):83

    PubMed  PubMed Central  Google Scholar 

  13. Wasserkort R, Kalmar A, Valcz G, Spisak S, Krispin M, Toth K, Tulassay Z, Sledziewski AZ, Molnar B (2013) Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island. BMC Cancer 13(398):1471–2407

    Google Scholar 

  14. Ravegnini G, Zolezzi Moraga JM, Maffei F, Musti M, Zenesini C, Simeon V, Sammarini G, Festi D, Hrelia P, Angelini S (2015) Simultaneous analysis of SEPT9 promoter methylation status, micronuclei frequency, and folate-related gene polymorphisms: the potential for a novel blood-based colorectal cancer biomarker. Int J Mol Sci 16(12):28486–28497

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Johnson DA, Barclay RL, Mergener K, Weiss G, König T, Beck J, Potter NT (2014) Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study. PLoS One 9(6):e98238

    PubMed  PubMed Central  Google Scholar 

  16. Molnár B, Tóth K, Barták BK, Tulassay Z (2015) Plasma methylated septin 9: a colorectal cancer screening marker. Expert Rev Mol Diagn 15(2):171–184

    PubMed  Google Scholar 

  17. Yan S, Liu Z, Yu S, Bao Y (2016) Diagnostic value of methylated septin9 for colorectal cancer screening: a meta-analysis. Med Sci Monit 22:3409–3418

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Song L, Jia J, Peng X, Xiao W, Li Y (2017) The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: a meta-analysis. Sci Rep 7(1):3032

    PubMed  PubMed Central  Google Scholar 

  19. Nian J, Xu Sun SM, Yan C, Ma Y, Feng Y, Yang L, Yu M, Zhang G, Wang X (2017) Diagnostic accuracy of methylated SEPT9 for blood-based colorectal Cancer detection: a systematic review and meta-analysis. Clin Transl Gastroenterol 8(1):e216

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Galanopoulos M, Tsoukalas N, Papanikolaou IS, Tolia M, Gazouli M, Mantzaris GJ (2017) Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: a review of literature. World J Gastrointest Oncol 9(4):142–152

    PubMed  PubMed Central  Google Scholar 

  21. Grützmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F, Roblick UJ (2008) Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 3(11):e3759

    PubMed  PubMed Central  Google Scholar 

  22. Baratloo A, Elfil M, Negida A (2015) Part 3: positive and negative likelihood ratios of diagnostic tests. Emergency 3(4):170–171

    PubMed  PubMed Central  Google Scholar 

  23. He Na CW, Yongqi L, Liping Y, Huahong X, Biaoluo W, Yongzhan N, Xin W, Xuegang G, Kaichun W (2014) Clinical significance of detecting serum methylated Sept9 gene in diagnosis of coloretal cancer. Chin J Dig 34(11):726–731

    Google Scholar 

  24. Chen CH, Yan SL, Yang TH, Chen SF, Yeh YH, Ou JJ, Lin CH, Lee YT, Chen CH (2017) The relationship between the methylated Septin-9 DNA blood test and stool occult blood test for diagnosing colorectal Cancer in Taiwanese people. J Clin Lab Anal 31(1)

    Google Scholar 

  25. Devos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C, Habermann JK (2009) Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 55(7):1337–1346

    CAS  PubMed  Google Scholar 

  26. He Q, Chen HY, Bai EQ, Luo YX, Fu RJ, He YS, Jiang J, Wang HQ (2010) Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. Cancer Genet Cytogenet 202(1):1–10

    CAS  PubMed  Google Scholar 

  27. Qiong HE, Wang M, Zhou JW, Liu N, Lai YR, Pathology DO (2015) Detection of ALX4 and SEPT9 methylation in human colorectal cancer by Multiplex MethyLight assay. J Sun Yat-Sen Univ (Med Sci) 36:657–662

    Google Scholar 

  28. Herbst A, Rahmig K, Stieber P, Philipp A, Jung A, Ofner A, Crispin A, Neumann J, Lamerz R, Kolligs FT (2011) Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal Cancer. Am J Gastroenterol 106(6):1110–1118

    CAS  PubMed  Google Scholar 

  29. Jin P, Kang Q, Wang X, Yang L, Yu Y, Li N, He YQ, Han X, Hang J, Zhang J (2015) Performance of a second generation methylated SEPT9 test in detecting colorectal neoplasm. J Gastroenterol Hepatol 30(5):830–833

    CAS  PubMed  Google Scholar 

  30. Kang Q, Jin P, Yang L, Wang X, An H, Liu L, Li N, Sheng J (2014) Significance of Septin9 gene methylation detection of plasma circulation DNA in colorectal cancer screening. Zhonghua Yi Xue Za Zhi 94(48):3839

    CAS  PubMed  Google Scholar 

  31. Lee HS, Hwang SM, Kim TS, Kim DW, Park DJ, Kang SB, Kim HH, Park KU (2013) Circulating methylated septin 9 nucleic acid in the plasma of patients with gastrointestinal cancer in the stomach and colon. Transl Oncol 6(3):290–296

    PubMed  PubMed Central  Google Scholar 

  32. Liu Y, Tham CK, Ong SYK, Ho KS, Lim JF, Min HC, Che KL, Yi Z, Tang CL, Kong WE (2013) Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study. Biomarkers 18(5):399–405

    CAS  PubMed  Google Scholar 

  33. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, Song X, Lesche R, Liebenberg V, Ebert M (2008) DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54(2):414–423

    CAS  PubMed  Google Scholar 

  34. Potter NT, Hurban P, White MN, Whitlock KD, Loftonday CE, Tetzner R, Koenig T, Quigley NB, Weiss G (2014) Validation of a real-time PCR–based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem 60(9):1183–1191

    CAS  PubMed  Google Scholar 

  35. Song L, Li Y, Jia J, Zhou G, Wang J, Kang Q, Jin P, Sheng J, Cai G, Cai S (2016) Algorithm optimization in methylation detection with multiple RT-qPCR. PLoS One 11(11):e0163333

    PubMed  PubMed Central  Google Scholar 

  36. Su XL, Wang YF, Li SJ, Zhang F, Cui HW (2014) High methylation of the SEPT9 gene in Chinese colorectal cancer patients. Genet Mol Res 13(2):2513–2520

    CAS  PubMed  Google Scholar 

  37. Tänzer M, Balluff B, Distler J, Hale K, Leodolter A, Röcken C, Molnar B, Schmid R, Lofton-Day C, Schuster T (2010) Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One 5(2):e9061

    PubMed  PubMed Central  Google Scholar 

  38. Tóth K, Wasserkort R, Sipos F, Kalmár A, Wichmann B, Leiszter K, Valcz G, Juhász M, Miheller P, Patai ÁV (2014) Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA. PLoS One 9(12):e115415

    PubMed  PubMed Central  Google Scholar 

  39. Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, Fang JC, Samowitz WS, Heichman KA (2011) Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med 9(1):133

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Wu Dong YH, Yue L, Jingnan L, Jiaming Q (2016) Detecting plasma methylated Septin9 gene combined with fecal immunochemical test in screening colorectal cancer and adenoma in outpatients. Chin J Dig 36(2):107–112

    Google Scholar 

  41. Wu D, Zhou G, Jin P, Zhu J, Li S, Wu Q, Wang G, Sheng J, Wang J, Song L (2016) Detection of colorectal Cancer using a simplified SEPT9 gene methylation assay is a reliable method for opportunistic screening. J Mol Diagn 18(4):535–545

    CAS  PubMed  Google Scholar 

  42. Qingqing D, Hao Z, Haichen X, Xiaolin L, Yun S, Qiping X, Weihao S (2015) Value of methylated Septin 9 detection in screening colorectal cancer in elderly people. Chinese Journal of Geriatrics 34(12):1348–1350

    Google Scholar 

  43. Shijie L, Yangang L, Jing W, Changqi C, Yan Y, Peng Y, Qi W (2015) The application of Septin9 methylation in screening of colorectal cancer using peripheral blood. Chinese Journal of General Surgery 24(12):1756–1760

    Google Scholar 

  44. Zhen W, Jiachang C, Qiong H, Huanyu P, Zhenyu Z, Huayun C, Ming L (2012) The methylation SEPT9 detection in the early diagnosis for colorectal cancer using MS-HRM. Guangdong Medical Journal 33(12):1732–1734

    Google Scholar 

  45. Ørntoft MB, Nielsen HJ, Ørntoft TF, Andersen CL (2015) Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study. BMC Cancer 15(819):015–1832

    Google Scholar 

  46. Tóth K, Sipos F, Kalmár A, Patai ÁV, Wichmann B, Stoehr R, Golcher H, Schellerer V, Tulassay Z, Molnár B (2012) Detection of methylated SEPT9 in plasma is a reliable screening method for both left-and right-sided colon cancers. PLoS One 7(9):e46000

    PubMed  PubMed Central  Google Scholar 

  47. Powrózek T, Krawczyk P, Kucharczyk T, Milanowski J (2014) Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report. Med Oncol 31(4):917

    PubMed  PubMed Central  Google Scholar 

  48. Beneish MD (1999) The detection of earnings manipulation. Financ Anal J 55(5):24–36

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of the Third general surgery, The Fourth Affiliated Hospital of the China Medical University, No. 4 Chongshan Road, Shenyang, 110032, China

    Gongping Sun, He Duan, Dewei Zhang & Yuanxin Tang

  2. Shenyang Anorectal Hospital, No. 9 North of Nanjing Street, Heping District, Shenyang, 110000, China

    Jin Meng

Authors
  1. Gongping Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. He Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dewei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuanxin Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dewei Zhang.

Ethics declarations

Conflict of Interest

The authors declare no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, G., Meng, J., Duan, H. et al. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis. Pathol. Oncol. Res. 25, 1525–1534 (2019). https://doi.org/10.1007/s12253-018-0559-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-018-0559-5

Keywords

Search

Navigation